The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,942,817 in first-year total cost, median $1,010,389.
Most frequent study sections
- Special Emphasis Panel[ZAI1 AWA-M (M1)]5
Most frequent institutions
- UNIVERSITY OF MARYLAND BALTIMORE2
- GLAXOSMITHKLINE BIOLOGICALS1
- MASSACHUSETTS GENERAL HOSPITAL1
- UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | Development of MecVax, a Cross Protective Subunit Vaccine for ETEC1R01AI177144-01 | ZHANG, WEIPING | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $1,170,694 | ZAI1 |
| 2023 | Advanced Development of a Combined Shigella-ETEC Vaccine1R01AI177145-01 | BARRY, EILEEN M.CHEN, WILBUR H. | UNIVERSITY OF MARYLAND BALTIMORE, MD | $1,053,471 | ZAI1 |
| 2023 | Shigella Conjugate Vaccine (SCV4) Development, Characterization, and Pre-clinical Evaluation1R01AI177075-01 | RYAN, EDWARD T. | MASSACHUSETTS GENERAL HOSPITAL, MA | $1,010,389 | ZAI1 |
| 2023 | O-polysaccharide (OPS)-IpaB Conjugate Vaccine to Prevent Shigellosis1R01AI177142-01 | PASETTI, MARCELA F | UNIVERSITY OF MARYLAND BALTIMORE, MD | $898,263 | ZAI1 |
| 2023 | Development of Robust and Low-cost Vaccines Against Salmonella Paratyphi A1R01AI177143-01 | CANALS ALVAREZ, ROCIO | GLAXOSMITHKLINE BIOLOGICALS | $810,000 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.